Warning
Reliance Life Sciences Private Limited Recalls Bortezomib for Injection 3.5mg/Vial
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0673-2026Drug / Pharmaceutical
Reliance Life Sciences Private Limited Recalls Bortezomib for Injection 3.5mg/Vial
Reliance Life Sciences Private Limited · Class II — Moderate Risk
Product Description
Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873. NDC: 70069-0836-01
Reason for Recall
Lack of Sterility Assurance
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
Nationwide in the USA
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
The FDA classified this recall as Class II, indicating the pharmaceutical product may cause temporary health problems or poses a slight threat of a serious nature. Reliance Life Sciences Private Limited initiated the recall on June 24, 2026 affecting 11,400 vials. Lack of Sterility Assurance. The product was distributed nationwide. Consumers should check their purchases and discontinue use of any affected product. Contact Reliance Life Sciences Private Limited for further instructions.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.